-20℃ 3 years powder
-80℃ 2 years in solvent
A-9758 is a RORγ ligand and a selective RORγt inverse agonist (IC50: 5 nM) and exhibits robust potency against IL-17A release. It is effective in suppressing both Th17 differentiation and Th17 effector function. A-9758 significantly attenuates IL-23 driven psoriasiform dermatitis.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | inquiry | inquiry | |
500 mg | inquiry | inquiry |
Description | A-9758 is a RORγ ligand and a selective RORγt inverse agonist (IC50: 5 nM) and exhibits robust potency against IL-17A release. It is effective in suppressing both Th17 differentiation and Th17 effector function. A-9758 significantly attenuates IL-23 driven psoriasiform dermatitis. |
Targets&IC50 | RORγt :ic50 5 nM, RORα :ic50 73 nM, RORβ :ic50 1370 nM, |
Molecular Weight | 527.36 |
Formula | C25H23Cl2F3N2O3 |
CAS No. | 2055271-22-0 |
-20℃ 3 years powder
-80℃ 2 years in solvent
( < 1 mg/ml refers to the product slightly soluble or insoluble )
Safe and effective drug dosing is necessary, regardless of its purpose of administration. Learn More
bottom
Answers to questions you may have can be found in the Inhibitor Handling Instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.